← Leaderboards
Alex K. Wong
University Of Southern California
$4,076,054
Attributed
$4,076,054
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $719.3K · FY2017–25$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,076,054 · 3
By mechanism
R01$3,193,446 · 1
K08$712,108 · 1
R03$170,500 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Southern California
Same institution · by research overlap
- Young-Kwon Hong$14,910,487
Others in their field
Other Emerging Leaders on “Quality Of Life”
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
- Martha Hering · Westat, Inc.$57,098,843
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Abraham Aizer Brody · New York University School Of Medicine$40,849,810
- Steven A. Ackerman · University Of Wisconsin-Madison$38,898,438
- Greg Yothers · University Of Chicago$35,003,821
Research focus
Quality Of LifeRecurrenceOperative Surgical ProceduresPreventLymphangiogenesisMalignant NeoplasmsLymph NodesMediatingLymphedemaPre-ClinicalIn VivoLaboratoriesAlitretinoinLimb StructureInjuryLymphaticDisabilityExcisionAffectInfectionLymphatic VesselFunctional DisorderIn VitroSwelling
Grant awards (12)
Retinoic Acid Induced Lymphangiogenesis for Post-Surgical Lymphedema$586,382
R01 · FY2025 · HL · contact PI
Retinoic Acid Induced Lymphangiogenesis for Post-Surgical Lymphedema$645,721
R01 · FY2024 · HL · contact PI
Retinoic Acid Induced Lymphangiogenesis for Post-surgical Lymphedema$703,342
R01 · FY2023 · HL · contact PI
Retinoic Acid Induced Lymphangiogenesis for Post-surgical Lymphedema$626,724
R01 · FY2022 · HL · contact PI
Retinoic Acid Induced Lymphangiogenesis for Post-surgical Lymphedema$631,277
R01 · FY2021 · HL · contact PI
Mitigation of lymphatic injury by retinoic acid therapyin a large animal model$88,000
R03 · FY2021 · HL · contact PI
Investigation of 9-cis Retinoic Acid as a Novel Treatment for Post-Surgical Lymphedema$152,376
K08 · FY2020 · HL · contact PI
Mitigation of lymphatic injury by retinoic acid therapy in a large animal model$82,500
R03 · FY2020 · HL · contact PI
Investigation of 9-cis Retinoic Acid as a Novel Treatment for Post-Surgical Lymphedema$25,651
K08 · FY2020 · HL · contact PI
Investigation of 9-cis Retinoic Acid as a Novel Treatment for Post-Surgical Lymphedema$178,027
K08 · FY2019 · HL · contact PI
Investigation of 9-cis Retinoic Acid as a Novel Treatment for Post-Surgical Lymphedema$178,027
K08 · FY2018 · HL · contact PI
Investigation of 9-cis Retinoic Acid as a Novel Treatment for Post-Surgical Lymphedema$178,027
K08 · FY2017 · HL · contact PI